Published in Proc Natl Acad Sci U S A on May 09, 2012
Excision of 5-hydroxymethyluracil and 5-carboxylcytosine by the thymine DNA glycosylase domain: its structural basis and implications for active DNA demethylation. Nucleic Acids Res (2012) 1.35
Recent advances in the structural mechanisms of DNA glycosylases. Biochim Biophys Acta (2012) 1.30
MBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological roles. Mutat Res (2012) 1.02
Role of base excision repair in maintaining the genetic and epigenetic integrity of CpG sites. DNA Repair (Amst) (2015) 1.01
Divergent mechanisms for enzymatic excision of 5-formylcytosine and 5-carboxylcytosine from DNA. J Am Chem Soc (2013) 0.93
Selective excision of 5-carboxylcytosine by a thymine DNA glycosylase mutant. J Mol Biol (2013) 0.89
Activity and crystal structure of human thymine DNA glycosylase mutant N140A with 5-carboxylcytosine DNA at low pH. DNA Repair (Amst) (2013) 0.84
Differential stabilities and sequence-dependent base pair opening dynamics of Watson-Crick base pairs with 5-hydroxymethylcytosine, 5-formylcytosine, or 5-carboxylcytosine. Biochemistry (2015) 0.83
E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex. J Biol Chem (2014) 0.81
Thymine DNA glycosylase exhibits negligible affinity for nucleobases that it removes from DNA. Nucleic Acids Res (2015) 0.80
How a mismatch repair enzyme balances the needs for efficient lesion processing and minimal action on undamaged DNA. Cell Cycle (2012) 0.80
The effect of a G:T mispair on the dynamics of DNA. PLoS One (2013) 0.79
Lesion search and recognition by thymine DNA glycosylase revealed by single molecule imaging. Nucleic Acids Res (2015) 0.78
Variations in brain DNA. Front Aging Neurosci (2014) 0.78
Aberrant repair initiated by mismatch-specific thymine-DNA glycosylases provides a mechanism for the mutational bias observed in CpG islands. Nucleic Acids Res (2014) 0.77
Structural basis of damage recognition by thymine DNA glycosylase: Key roles for N-terminal residues. Nucleic Acids Res (2016) 0.77
Structural and mutation studies of two DNA demethylation related glycosylases: MBD4 and TDG. Biophysics (Nagoya-shi) (2014) 0.75
Mechanisms of glycosylase induced genomic instability. PLoS One (2017) 0.75
Structural Basis for Excision of 5-Formylcytosine by Thymine DNA Glycosylase. Biochemistry (2016) 0.75
Structure of a DNA glycosylase that unhooks interstrand cross-links. Proc Natl Acad Sci U S A (2017) 0.75
Role of Base Excision "Repair" Enzymes in Erasing Epigenetic Marks from DNA. Chem Rev (2016) 0.75
Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
CHARMM: the biomolecular simulation program. J Comput Chem (2009) 27.71
Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem (2004) 17.97
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science (2011) 14.29
Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science (2011) 13.16
Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol (2010) 9.35
Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell (2011) 9.16
The CpG dinucleotide and human genetic disease. Hum Genet (1988) 7.86
Quality control by DNA repair. Science (1999) 7.71
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell (2011) 6.80
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science (1990) 4.80
Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J Biol Chem (2011) 4.64
The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature (1999) 4.63
Structure of a repair enzyme interrogating undamaged DNA elucidates recognition of damaged DNA. Nature (2005) 3.67
Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature (2011) 3.28
Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science (2002) 2.73
Abasic sites in DNA: repair and biological consequences in Saccharomyces cerevisiae. DNA Repair (Amst) (2004) 2.71
Specificity of human thymine DNA glycosylase depends on N-glycosidic bond stability. J Am Chem Soc (2006) 2.52
Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA. Nat Chem Biol (2012) 2.45
Mismatch-specific thymine DNA glycosylase and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells. Proc Natl Acad Sci U S A (1990) 2.42
Enzymatic capture of an extrahelical thymine in the search for uracil in DNA. Nature (2007) 2.29
Mutational spectra of human cancer. Hum Genet (2009) 2.26
Uracil-DNA glycosylase-DNA substrate and product structures: conformational strain promotes catalytic efficiency by coupled stereoelectronic effects. Proc Natl Acad Sci U S A (2000) 2.24
A new class of uracil-DNA glycosylases related to human thymine-DNA glycosylase. Nature (1996) 2.21
Crystal structure of a G:T/U mismatch-specific DNA glycosylase: mismatch recognition by complementary-strand interactions. Cell (1998) 2.20
Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase. J Biol Chem (1996) 2.14
Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature (2005) 2.11
Excision of cytosine and thymine from DNA by mutants of human uracil-DNA glycosylase. EMBO J (1996) 2.07
Separating substrate recognition from base hydrolysis in human thymine DNA glycosylase by mutational analysis. J Biol Chem (2000) 2.03
Dissecting the broad substrate specificity of human 3-methyladenine-DNA glycosylase. J Biol Chem (2003) 1.82
Protein-facilitated base flipping in DNA by cytosine-5-methyltransferase. Proc Natl Acad Sci U S A (2002) 1.78
Uracil-DNA glycosylase acts by substrate autocatalysis. Nature (2001) 1.77
Detection of damaged DNA bases by DNA glycosylase enzymes. Biochemistry (2010) 1.76
DNA glycosylase recognition and catalysis. Curr Opin Struct Biol (2004) 1.74
Crystal structure of a thwarted mismatch glycosylase DNA repair complex. EMBO J (1999) 1.62
Crystal structure of human thymine DNA glycosylase bound to DNA elucidates sequence-specific mismatch recognition. Proc Natl Acad Sci U S A (2008) 1.58
Kinetics of the action of thymine DNA glycosylase. J Biol Chem (1998) 1.56
Structure and specificity of the vertebrate anti-mutator uracil-DNA glycosylase SMUG1. Mol Cell (2003) 1.49
Excision of 5-halogenated uracils by human thymine DNA glycosylase. Robust activity for DNA contexts other than CpG. J Biol Chem (2007) 1.46
Kinetic isotope effect studies of the reaction catalyzed by uracil DNA glycosylase: evidence for an oxocarbenium ion-uracil anion intermediate. Biochemistry (2000) 1.45
Coordinating the initial steps of base excision repair. Apurinic/apyrimidinic endonuclease 1 actively stimulates thymine DNA glycosylase by disrupting the product complex. J Biol Chem (2008) 1.43
Computational approaches for investigating base flipping in oligonucleotides. Chem Rev (2006) 1.35
Transition-state analysis of the DNA repair enzyme MutY. J Am Chem Soc (2008) 1.29
The curious chemical biology of cytosine: deamination, methylation, and oxidation as modulators of genomic potential. ACS Chem Biol (2011) 1.25
Investigation of the mechanisms of DNA binding of the human G/T glycosylase using designed inhibitors. Proc Natl Acad Sci U S A (1997) 1.25
Thymine-DNA glycosylase and G to A transition mutations at CpG sites. Mutat Res (2000) 1.24
Role of two strictly conserved residues in nucleotide flipping and N-glycosylic bond cleavage by human thymine DNA glycosylase. J Biol Chem (2009) 1.21
Stoichiometry and affinity for thymine DNA glycosylase binding to specific and nonspecific DNA. Nucleic Acids Res (2010) 1.17
Mismatch repair in methylated DNA. Structure and activity of the mismatch-specific thymine glycosylase domain of methyl-CpG-binding protein MBD4. J Biol Chem (2002) 1.16
Crystal structure of SUMO-3-modified thymine-DNA glycosylase. J Mol Biol (2006) 1.09
Electrostatic guidance of glycosyl cation migration along the reaction coordinate of uracil DNA glycosylase. Biochemistry (2003) 1.07
Caught in the act: visualization of an intermediate in the DNA base-flipping pathway induced by HhaI methyltransferase. Nucleic Acids Res (2004) 1.03
Dependence of substrate binding and catalysis on pH, ionic strength, and temperature for thymine DNA glycosylase: Insights into recognition and processing of G·T mispairs. DNA Repair (Amst) (2011) 1.03
Percentile-based spread: a more accurate way to compare crystallographic models. Acta Crystallogr D Biol Crystallogr (2010) 0.92
Rational engineering of a DNA glycosylase specific for an unnatural cytosine:pyrene base pair. Chem Biol (2003) 0.91
Active-site clashes prevent the human 3-methyladenine DNA glycosylase from improperly removing bases. Chem Biol (2002) 0.89
Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J Phys Chem B (2010) 8.70
Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J Biol Chem (2011) 4.64
An ab initio study on the torsional surface of alkanes and its effect on molecular simulations of alkanes and a DPPC bilayer. J Phys Chem B (2005) 3.32
Importance of the CMAP correction to the CHARMM22 protein force field: dynamics of hen lysozyme. Biophys J (2005) 2.84
Polyunsaturated fatty acids in lipid bilayers: intrinsic and environmental contributions to their unique physical properties. J Am Chem Soc (2002) 2.76
Polarizable empirical force field for alkanes based on the classical Drude oscillator model. J Phys Chem B (2005) 2.56
Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell (2011) 2.55
Specificity of human thymine DNA glycosylase depends on N-glycosidic bond stability. J Am Chem Soc (2006) 2.52
Free energy and structural pathways of base flipping in a DNA GCGC containing sequence. J Mol Biol (2002) 1.95
Automated conformational energy fitting for force-field development. J Mol Model (2008) 1.84
CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem (2013) 1.82
Protein-facilitated base flipping in DNA by cytosine-5-methyltransferase. Proc Natl Acad Sci U S A (2002) 1.78
The structure of aqueous guanidinium chloride solutions. J Am Chem Soc (2004) 1.66
Computational fragment-based binding site identification by ligand competitive saturation. PLoS Comput Biol (2009) 1.61
Crystal structure of human thymine DNA glycosylase bound to DNA elucidates sequence-specific mismatch recognition. Proc Natl Acad Sci U S A (2008) 1.58
Understanding the dielectric properties of liquid amides from a polarizable force field. J Phys Chem B (2008) 1.57
Ab initio modeling of glycosyl torsions and anomeric effects in a model carbohydrate: 2-ethoxy tetrahydropyran. Biophys J (2007) 1.48
Excision of 5-halogenated uracils by human thymine DNA glycosylase. Robust activity for DNA contexts other than CpG. J Biol Chem (2007) 1.46
Consolidation of glycosyl hydrolase family 30: a dual domain 4/7 hydrolase family consisting of two structurally distinct groups. FEBS Lett (2010) 1.43
Coordinating the initial steps of base excision repair. Apurinic/apyrimidinic endonuclease 1 actively stimulates thymine DNA glycosylase by disrupting the product complex. J Biol Chem (2008) 1.43
Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction. J Med Chem (2004) 1.41
Intrinsic conformational energetics associated with the glycosyl torsion in DNA: a quantum mechanical study. Biophys J (2002) 1.40
Consideration of molecular weight during compound selection in virtual target-based database screening. J Chem Inf Comput Sci (2003) 1.37
2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists. J Am Chem Soc (2003) 1.36
Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res (2008) 1.36
Computational approaches for investigating base flipping in oligonucleotides. Chem Rev (2006) 1.35
Is arginine charged in a membrane? Biophys J (2007) 1.33
Combined ab initio/empirical approach for optimization of Lennard-Jones parameters for polar-neutral compounds. J Comput Chem (2002) 1.32
Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol (2002) 1.29
Visualizing ligand molecules in Twilight electron density. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 1.29
A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. Cell Rep (2013) 1.28
Computational evaluation of protein-small molecule binding. Curr Opin Struct Biol (2009) 1.27
Cysteine pKa depression by a protonated glutamic acid in human DJ-1. Biochemistry (2008) 1.26
Rapid Crystallization of L-Alanine on Engineered Surfaces using Metal-Assisted and Microwave-Accelerated Evaporative Crystallization. Cryst Growth Des (2012) 1.23
Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity. J Med Chem (2007) 1.22
Role of two strictly conserved residues in nucleotide flipping and N-glycosylic bond cleavage by human thymine DNA glycosylase. J Biol Chem (2009) 1.21
Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations. J Comput Chem (2012) 1.20
Comparison of protein force fields for molecular dynamics simulations. Methods Mol Biol (2008) 1.19
The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates DNA repair enzyme TDG glycosylase. Nucleic Acids Res (2007) 1.19
CHARMM force field parameters for simulation of reactive intermediates in native and thio-substituted ribozymes. J Comput Chem (2007) 1.18
Stoichiometry and affinity for thymine DNA glycosylase binding to specific and nonspecific DNA. Nucleic Acids Res (2010) 1.17
All-atom polarizable force field for DNA based on the classical Drude oscillator model. J Comput Chem (2014) 1.16
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo. PLoS One (2012) 1.15
Computational identification of inhibitors of protein-protein interactions. Curr Top Med Chem (2007) 1.14
CHARMM additive all-atom force field for glycosidic linkages in carbohydrates involving furanoses. J Phys Chem B (2010) 1.12
Inclusion of many-body effects in the additive CHARMM protein CMAP potential results in enhanced cooperativity of α-helix and β-hairpin formation. Biophys J (2012) 1.12
Identification and validation of human DNA ligase inhibitors using computer-aided drug design. J Med Chem (2008) 1.10
Divalent metal ion complexes of S100B in the absence and presence of pentamidine. J Mol Biol (2008) 1.09
Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach. J Chem Inf Model (2013) 1.09
The role of bias in crystallization conditions in automated microseeding. Acta Crystallogr D Biol Crystallogr (2008) 1.08
Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site. J Med Chem (2004) 1.07
Development of CHARMM polarizable force field for nucleic acid bases based on the classical Drude oscillator model. J Phys Chem B (2010) 1.07
Altered structural fluctuations in duplex RNA versus DNA: a conformational switch involving base pair opening. Nucleic Acids Res (2003) 1.05
Atomistic view of base flipping in DNA. Philos Trans A Math Phys Eng Sci (2004) 1.05
The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak. Mol Cancer (2013) 1.04
Dependence of substrate binding and catalysis on pH, ionic strength, and temperature for thymine DNA glycosylase: Insights into recognition and processing of G·T mispairs. DNA Repair (Amst) (2011) 1.03
Caught in the act: visualization of an intermediate in the DNA base-flipping pathway induced by HhaI methyltransferase. Nucleic Acids Res (2004) 1.03
Glycan Reader: automated sugar identification and simulation preparation for carbohydrates and glycoproteins. J Comput Chem (2011) 1.02
The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography. J Mol Biol (2010) 1.01
A polarizable force field of dipalmitoylphosphatidylcholine based on the classical Drude model for molecular dynamics simulations of lipids. J Phys Chem B (2013) 1.01
Role of the adenine ligand on the stabilization of the secondary and tertiary interactions in the adenine riboswitch. J Mol Biol (2009) 1.01
Targeting NAD biosynthesis in bacterial pathogens: Structure-based development of inhibitors of nicotinate mononucleotide adenylyltransferase NadD. Chem Biol (2009) 1.01
Specificity in protein-DNA interactions: energetic recognition by the (cytosine-C5)-methyltransferase from HhaI. J Mol Biol (2005) 1.00
Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors. Org Biomol Chem (2012) 0.98
Binding response: a descriptor for selecting ligand binding site on protein surfaces. J Chem Inf Model (2007) 0.97
Probing the limits of electrostatic catalysis by uracil DNA glycosylase using transition state mimicry and mutagenesis. J Biol Chem (2002) 0.97
Balancing target flexibility and target denaturation in computational fragment-based inhibitor discovery. J Comput Chem (2012) 0.96
Ligand bound structures of a glycosyl hydrolase family 30 glucuronoxylan xylanohydrolase. J Mol Biol (2011) 0.96
Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure. Bioorg Med Chem Lett (2006) 0.95
Balancing the interactions of ions, water, and DNA in the Drude polarizable force field. J Phys Chem B (2014) 0.94
Polarizable empirical force field for sulfur-containing compounds based on the classical Drude oscillator model. J Comput Chem (2010) 0.94
N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo. J Biol Chem (2011) 0.94
Conformational determinants of tandem GU mismatches in RNA: insights from molecular dynamics simulations and quantum mechanical calculations. Biochemistry (2005) 0.93
Divergent mechanisms for enzymatic excision of 5-formylcytosine and 5-carboxylcytosine from DNA. J Am Chem Soc (2013) 0.93
Crystal structure of human methyl-binding domain IV glycosylase bound to abasic DNA. J Mol Biol (2012) 0.93
Polarizable empirical force field for hexopyranose monosaccharides based on the classical Drude oscillator. J Phys Chem B (2014) 0.93
Solution structure and base perturbation studies reveal a novel mode of alkylated base recognition by 3-methyladenine DNA glycosylase I. J Biol Chem (2003) 0.92
Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity. J Bone Miner Res (2012) 0.91
Molecular simulations of dodecyl-β-maltoside micelles in water: influence of the headgroup conformation and force field parameters. J Phys Chem B (2010) 0.90
Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities. ACS Chem Neurosci (2013) 0.90
Six-site polarizable model of water based on the classical Drude oscillator. J Chem Phys (2013) 0.90
Simulation study of ion pairing in concentrated aqueous salt solutions with a polarizable force field. Faraday Discuss (2013) 0.90
Inactivation of Escherichia coli L-aspartate aminotransferase by (S)-4-amino-4,5-dihydro-2-thiophenecarboxylic acid reveals "a tale of two mechanisms". Biochemistry (2007) 0.90
A conserved protein interaction interface on the type 5 G protein beta subunit controls proteolytic stability and activity of R7 family regulator of G protein signaling proteins. J Biol Chem (2010) 0.90
Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling. J Comput Aided Mol Des (2014) 0.89
Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography. Biochemistry (2009) 0.89
Inhibition of the bacterial heme oxygenases from Pseudomonas aeruginosa and Neisseria meningitidis: novel antimicrobial targets. J Med Chem (2007) 0.89
Influence of solvent and intramolecular hydrogen bonding on the conformational properties of o-linked glycopeptides. J Phys Chem B (2011) 0.89
Position of coordination of the lithium ion determines the regioselectivity of demethylations of 3,4-dimethoxymorphinans with L-selectride. Org Lett (2005) 0.89
Rapid estimation of hydration thermodynamics of macromolecular regions. J Chem Phys (2013) 0.89
Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9. BMC Cancer (2011) 0.88
Tyr66 acts as a conformational switch in the closed-to-open transition of the SHP-2 N-SH2-domain phosphotyrosine-peptide binding cleft. BMC Struct Biol (2007) 0.88
Holo-Ni(II)HpNikR is an asymmetric tetramer containing two different nickel-binding sites. J Am Chem Soc (2010) 0.88
Conformational properties of α- or β-(1→6)-linked oligosaccharides: Hamiltonian replica exchange MD simulations and NMR experiments. J Phys Chem B (2014) 0.88
Differential Impact of the Monovalent Ions Li⁺, Na⁺, K⁺, and Rb⁺ on DNA Conformational Properties. J Phys Chem Lett (2015) 0.87